Vnitr Lek 2010, 56(Suppl 1):109-111

The application of IPF (Immature platelet fraction) in laboratory diagnostics

M. Ryzí*, J. Gumulec
Ústav klinické hematologie FN Ostrava, přednosta prim. MUDr. Jaromír Gumulec

Young platelets - reticulated platelets - are a marker of the thromopoiesis. The determination of reticulated platelets can be used to a laboratory diagnosis of thrombocytopenias and to the monitoring of a platelet kinetics after the chemotherapy and after bone marrow transplantation. Reticulated platelets have been measured by flow cytometry. This determination has been expensive, time spending and it has been never standardise. Now it is possible to measure young platelets as a part of the full blood count by the haematological analyser Sysmex XE-5 000. Reticulated platelets are named as IPF (Immature platelet fraction) in this analyser.

Keywords: reticulated platelets; IPF; throbocytopenia

Received: April 30, 2010; Published: February 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ryzí M, Gumulec J. The application of IPF (Immature platelet fraction) in laboratory diagnostics. Vnitr Lek. 2010;56(Supplementum 1):109-111.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Harrison P. Platelet development. Sysmex Journal Intern 2007; 2: 73-80.
    2. Doporučení České hematologické společnosti (www.hematology.cz)
    3. Kaushansky K. The molecular mechanisms that control thrombopoiesis. J Clin Invest 2005; 115: 3339-3347. Go to original source... Go to PubMed...
    4. Ingram M., Coopersmith A. Reticulated platelets following acute blood loss. Br J Haematol 1969; 17: 225-229. Go to original source... Go to PubMed...
    5. Kienast J, Schmitz G. Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic iad in the evaluation of thrombocytopenic disorders. Blood 1990; 75: 116-121. Go to original source...
    6. Sugimori N, Kondo Y, Shibayama M et al. Aberrant increase in the immature platelet fraction in patients with myelodysplastic syndrome: a marker of karyotypic abnormalities associated with poor prognosis. Eur J Haematol 2008; 82: 54-60. Go to original source... Go to PubMed...
    7. Briggs C, Kunka S, Hart D et al. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol 2004; 126: 93-99. Go to original source... Go to PubMed...
    8. Briggs C, Hart D, Kunka S et al. Immature platelet fraction measurement: a future guide to platelet transfusion requirement after heamatopoietic stem cell transplantation. Trans Med 2006; 16: 101-109. Go to original source... Go to PubMed...
    9. Takami A, Shibayama M, Orito M et al. Immature platelet fraction for prediction of platelet engrafment after allogenic stem cell transplantation. Bone Marrow Transplant 2007; 39: 501-507. Go to original source... Go to PubMed...
    10. Osei-Bimpong A. The effect of storage on the clinical utility of the immature platelet fraction. Hematology 2009; 14: 118-121. Go to original source... Go to PubMed...
    11. Abe Y, Wada H, Tomatsu H et al. A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). Tromb Res 2006; 118: 463-469. Go to original source... Go to PubMed...
    12. Zucker ML, Murphy CA, Rachel JM et al. Immature platelet fraction as a predictor of platelet recovery following hematopoietic progenitor cell transplantation. Lab Haematol 2006; 12: 125-130. Go to original source... Go to PubMed...
    13. Grove EL, Hvas AM, Kristensen SD. Immature platelets in patients with acute coronary syndromes. Tromb Haemost 2009; 101: 151-156. Go to original source...
    14. Saigo K, Sakota Y, Masuda Y et al. Clinical utility of new parameters provided by Sysmex XE-2100 RET Channel. Sysmex Journal Intern 2007; 17: 81-94.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.